Stockreport

Krystal Biotech (KRYS) Is Up 5.9% After Positive KB407 CF Gene Therapy Data And FDA Study Filing [Yahoo! Finance]

Krystal Biotech, Inc.  (KRYS) 
Last krystal biotech, inc. earnings: 11/4 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.krystalbio.com/investors
PDF inhaled delivery of KB407 to the lungs of cystic fibrosis patients with confirmed expression of wild-type CFTR protein and a generally mild-to-moderate safety profile. [Read more]